- United States
- /
- Software
- /
- NYSE:PATH
Will UiPath's (PATH) Move Into AI Security Shape Its Long-Term Competitive Edge?
- Earlier this month, the Artificial Intelligence Underwriting Company (AIUC) announced that UiPath has become a founding technical contributor to AIUC-1, a leading enterprise security framework for AI agent adoption rooted in global standards and third-party audits.
- UiPath’s involvement underscores its commitment to strengthening AI security and compliance for organizations using autonomous agent technologies in critical workflows.
- Now, let's explore how UiPath’s new leadership role in AI enterprise security could influence its investment narrative going forward.
AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
UiPath Investment Narrative Recap
To be a UiPath shareholder, it's important to believe in the company's ability to capitalize on enterprise automation and AI security, backed by deep partnerships and robust compliance standards. The recent announcement of UiPath’s role as a founding technical contributor to the AIUC-1 enterprise security framework signals commitment to trusted AI adoption, yet is unlikely to materially shift the immediate revenue impact of delayed enterprise deals or challenges posed by macroeconomic uncertainty in the short term.
Of UiPath’s recent announcements, the multi-faceted collaboration with NVIDIA stands out in relation to the AIUC-1 news. Both focus on advancing secure and efficient AI-led automation in business-critical areas, whether through joint technical frameworks or applied AI in sensitive sectors, highlighting how UiPath is positioning its platform as a key enabler for secure, compliant workflow automation as adoption of autonomous agents accelerates.
But in contrast, investors should be aware of how ongoing geopolitical delays in enterprise deal closures have ...
Read the full narrative on UiPath (it's free!)
UiPath's outlook anticipates $1.9 billion in revenue and $243.6 million in earnings by 2028. This projection assumes an 8.6% annual revenue growth rate and a $311.1 million increase in earnings from the current level of -$67.5 million.
Uncover how UiPath's forecasts yield a $13.86 fair value, in line with its current price.
Exploring Other Perspectives
The Simply Wall St Community shared 13 fair value estimates for UiPath ranging from US$13.70 to US$30.00, showing broad differences in outlook. Your view on the company’s ability to overcome delayed enterprise deal closures could be a key factor shaping performance in the months ahead, explore the many perspectives and decide what matters most to you.
Explore 13 other fair value estimates on UiPath - why the stock might be worth over 2x more than the current price!
Build Your Own UiPath Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your UiPath research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
- Our free UiPath research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate UiPath's overall financial health at a glance.
Ready For A Different Approach?
The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:
- Uncover the next big thing with financially sound penny stocks that balance risk and reward.
- Rare earth metals are the new gold rush. Find out which 35 stocks are leading the charge.
- This technology could replace computers: discover 28 stocks that are working to make quantum computing a reality.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:PATH
UiPath
Provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally.
Flawless balance sheet and undervalued.
Similar Companies
Market Insights
Weekly Picks

An Undervalued 3.3Moz Gold Project in Canada
Coca-Cola’s Enduring Moat in a Health-Conscious World: Steady Compounder Poised for 5-10% Annual Returns Through Emerging Market Dominance
Xero: Growth Was Priced In — Execution Is Not
Nu holdings will continue to disrupt the South American banking market
Recently Updated Narratives
TLX... a Market's Overreaction or a Falling Knife?
Rally in sustainable practices over value recyclable metal stock

Regeneron Pharmaceuticals Inc. (REGN): The Biotech Stalwart – Defensive Growth Amid Biosimilar Headwinds in 2026.
Popular Narratives

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

